A human CXCL13-induced actin polymerization assay measured by fluorescence plate reader.
The chemokine receptor CXCR5 is predominantly expressed on mature B cells and follicular T-helper cells. CXCR5 and its ligand CXCL13 participate in ectopic germinal center formation at the inflammatory sites of multiple immune diseases such as rheumatoid arthritis, multiple sclerosis, and Sjogren's syndrome. Therefore, disrupting CXCL13-induced chemotaxis may be a fruitful approach for developing therapeutics in treating these diseases. Cells undergo cytoskeletal rearrangement prior to chemotaxis, and therefore actin polymerization can be used as a surrogate readout more proximal to chemokine receptor activation than chemotaxis. Conventionally, actin polymerization is measured by fluorescence microscopy or flow cytometry, which are either of low throughput or in need of special instruments. We developed a 96-well actin polymerization assay that can process 1,000 to 1,500 samples a day. This assay uses a standard laboratory fluorescence microplate reader as the detection instrument and was optimized for various experimental conditions such as cell density, actin filament staining reagent, staining buffer, and cell culture conditions. We demonstrate that this actin polymerization assay in 96-well format exhibits the expected pharmacology for human CXCR5 and is suitable as a primary functional assay to screen neutralizing scFv in crude bacterial peri-preps and a secondary assay for small compound collections.
Alley
Jennifer
J
Pfizer Inflammation and Immunology, Cambridge, Massachusetts 02140, USA.
Bloom
Laird
L
Kasaian
Marion
M
Gao
Huilan
H
Berstein
Gabriel
G
Clark
James D
JD
Miao
Wenyan
W
D000199:Actins / Q000378:metabolism*; D000818:Animals; D002452:Cell Count; D002460:Cell Line; D054382:Chemokine CXCL13 / Q000494:pharmacology*; D005434:Flow Cytometry; D005453:Fluorescence; D006801:Humans; D051379:Mice; D018613:Microscopy, Confocal; D013696:Temperature
D000199:Actins; C110663:CXCL13 protein, human; D054382:Chemokine CXCL13